Iovance Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Iovance Biotherapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $20M | 2.7M | 7.40 |
2024-09-30 | $5.8M | 622k | 9.39 |
2024-06-30 | $6.4M | 795k | 8.02 |
2024-03-31 | $10M | 691k | 14.82 |
2023-12-31 | $7.0M | 857k | 8.13 |
2023-09-30 | $1.1M | 241k | 4.55 |
2023-06-30 | $3.3M | 470k | 7.04 |
2023-03-31 | $2.6M | 427k | 6.11 |
2022-12-31 | $5.1M | 798k | 6.39 |
2022-09-30 | $1.0M | 106k | 9.58 |
2022-06-30 | $1.0M | 95k | 11.04 |
2022-03-31 | $5.9M | 360k | 16.52 |
2021-12-31 | $4.2M | 220k | 19.09 |
2021-09-30 | $4.8M | 196k | 24.65 |
2021-06-30 | $0 | 63k | 0.00 |
2021-03-31 | $3.1M | 98k | 31.65 |
2020-12-31 | $4.0M | 86k | 46.38 |
2020-09-30 | $2.4M | 72k | 32.92 |
2020-06-30 | $1.2M | 45k | 27.44 |
2020-03-31 | $832k | 28k | 29.94 |
2019-12-31 | $4.3M | 156k | 27.67 |
2019-09-30 | $6.8M | 376k | 18.20 |
2019-06-30 | $3.2M | 132k | 24.52 |
2019-03-31 | $98k | 10k | 9.56 |
2018-12-31 | $2.4M | 270k | 8.86 |
2018-09-30 | $512k | 46k | 11.22 |
2018-06-30 | $95k | 7.4k | 12.92 |
2018-03-31 | $1.0M | 61k | 16.99 |
2017-12-31 | $11k | 1.4k | 7.88 |
2017-09-30 | $62k | 8.0k | 7.75 |
2017-06-30 | $67k | 9.1k | 7.38 |